Cargando…
Curative Cell and Gene Therapy for Osteogenesis Imperfecta
Osteogenesis imperfecta (OI) describes a series of genetic bone fragility disorders that can have a substantive impact on patient quality of life. The multidisciplinary approach to management of children and adults with OI primarily involves the administration of antiresorptive medication, allied he...
Autores principales: | Schindeler, Aaron, Lee, Lucinda R, O'Donohue, Alexandra K, Ginn, Samantha L, Munns, Craig F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324990/ https://www.ncbi.nlm.nih.gov/pubmed/35306687 http://dx.doi.org/10.1002/jbmr.4549 |
Ejemplares similares
-
Effect of osteogenesis imperfecta on children and their families
por: Dung, Vu Chi, et al.
Publicado: (2013) -
Osteogenesis imperfecta
por: Vitturi, Bruno Kusznir, et al.
Publicado: (2018) -
Osteogenesis Imperfecta
por: Sam, Justin Easow, et al.
Publicado: (2017) -
Osteogenesis Imperfecta: Current and Prospective Therapies
por: Botor, Malwina, et al.
Publicado: (2021) -
Induction of periosteal bone formation by intraosseous BMP-2 injection in a mouse model of osteogenesis imperfecta
por: Cheng, T. L., et al.
Publicado: (2019)